BRBS

#3177
Blue Ridge Bankshares, Inc. Common Stock
3.9 4 USD
+0.01%
Market Price
Sektor: Finanzen
Basis: USD
Gewinnwährung: USD
Tagesspanne
3.93
3.95
Jahresspanne
3.23
4.79
Tagesänderung
+1.03%
Monatliche Änderung
+11.61%
6 month change
-2.72%
Jahresänderung
-10.04%
Vorheriger Schlusskurs
3.9 0
Open
3.9 5
Tief
3.9 3
Hoch
3.9 5
Volumen
362
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden Documents

2026

Current report, 16 Aug 2026
BLUE RIDGE BANKSHARES, INC. current report, 16 August 2026
8-K
Current report, Q3 FY2026
BLUE RIDGE BANKSHARES, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
BLUE RIDGE BANKSHARES, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
BLUE RIDGE BANKSHARES, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
BLUE RIDGE BANKSHARES, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
BLUE RIDGE BANKSHARES, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
BLUE RIDGE BANKSHARES, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
BLUE RIDGE BANKSHARES, INC. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
BLUE RIDGE BANKSHARES, INC. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
BLUE RIDGE BANKSHARES, INC. current report, Q1 FY2026
8-K

BLUE RIDGE BANKSHARES, INC. current report, Q2 FY2024

Full document

Business Context and Reporting Period

Company: Blue Ridge Bankshares, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 13, 2024
Event: Completion of a private placement transaction involving the issuance of common stock, preferred stock, and warrants to a shareholder.

Key Financial Metrics

Transaction Proceeds: Approximately $11.6 million in gross proceeds.
Securities Issued:

  • 290,000 shares of Common Stock at $2.39 per share.
  • 1,140 shares of Mandatorily Convertible Cumulative Perpetual Preferred Stock, Series B, at $9,566.13 per share.
  • One warrant to purchase 607 shares of Series B Preferred Stock at an exercise price of $10,000.00 per share.
Other Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity outside of the transaction proceeds.

Material Changes

The primary material change is the capital raise via the Private Placement closed on June 13, 2024. This follows a Securities Purchase Agreement entered into on June 7, 2024, with Richard T. Spurzem, a shareholder of the Company. The transaction resulted in the immediate issuance of equity securities and a warrant.

Guidance, Outlook, and Risks

Management Commentary: The filing confirms the execution of previously disclosed terms regarding the Securities Purchase Agreement, Warrant, and Registration Rights Agreement.
Risks and Contingencies:

  • The securities sold were unregistered under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
  • The securities are subject to resale restrictions under the Securities Act and may not be offered or sold absent registration or an applicable exemption.
  • The filing explicitly states it does not constitute an offer to sell securities in any jurisdiction where such an offer would be unlawful.
Guidance: The filing text does not provide clear values or statements regarding future financial guidance or outlook.

Investor Verification Checklist

  • Verify the exact terms of the Warrant and Registration Rights Agreement filed as Exhibits 4.1 and 10.1.
  • Confirm the impact of the $11.6 million capital raise on the company's balance sheet and liquidity position in subsequent filings.
  • Review the June 11, 2024 Form 8-K for the full background of the Securities Purchase Agreement.
  • Monitor for any future registration statements required to lift resale restrictions on the issued securities.

Nachrichten